Lithium–Titanium Exchange of Bis(1-sulfonylalkyl)titaniums
8.10 mmol) in THF as described in GP5 gave alcohol 13a (1.005 g,
85%) as pale-yellow crystals, m.p. 174–176 °C, Rf = 0.53 (EtOAc/
From Putative 15Ac and PhCHO: Treatment of sulfone 8c (750 mg,
3.78 mmol) with nBuLi (1.50 m in n-hexane, 2.80 mL, 4.20 mmol),
n-hexane, 1:1). 1H NMR (300 MHz, CDCl3): δ = 0.94 (s, 3 H, Me), ClTi(OiPr)3 (1.183 g, 4.54 mmol) and PhCHO (864 mg, 8.14 mmol)
1.41 (s, 3 H, Me), 4.24 (s, 1 H, OH), 5.19 (s, 1 H, CHO), 7.30–7.96
(m, 10 H, Ph) ppm. 13C NMR (75 MHz, CDCl3): δ = 13.9 (d, Me),
21.6 (d, Me), 66.7 (u, CS), 74.7 (d, CO), 128.00 (d, Ph), 128.03 (d,
Ph), 129.0 (d, Ph), 130.5 (d, Ph), 128.3 (d, Ph), 134.2 (d, Ph), 134.9
in THF as described in GP5 gave a mixture of diastereomeric
alcohols 13c (862 mg, 75%) as colourless crystals, m.p. 130 °C, Rf
= 0.62 (EtOAc/n-hexane, 1:1). 1H NMR (300 MHz, CDCl3): δ =
0.52 (dd, J = 7.4 Hz, 3 HA, CH3CH2), 0.98 (dd, J = 7.6 Hz, 3 HB,
(d, Ph), 137.9 (u, Ph) ppm. IR (KBr): ν = 3905 (w), 3547 (vs), 3087 CH3CH2), 1.05 (s, 3 HA, Me), 1.35 (dq, J = 7.5, 15.1 Hz, 1 HA,
˜
(m), 3052 (m), 3029 (m), 3000 (m), 2969 (m), 2937 (m), 2196 (w), CH3CH2), 1.46 (s, 3 HB, Me), 1.49 (dq, J = 7.5, 15.1 Hz, 1 HA,
1967 (w), 1914 (w), 1831 (w), 1601 (m), 1581 (m), 1494 (m), 1450
(s), 1386 (s), 1368 (m), 1338 (m), 1284 (vs), 1189 (s), 1148 (vs), 1122
CH3CH2), 1.95 (dq, J = 7.6, 15.4 Hz, 1 HB, CH3CH2), 2.29 (dq, J
= 7.6, 15.4 Hz, 1 HB, CH3CH2), 4.27 (d, J = 1.4 Hz, 1 HA, OH),
(vs), 1074 (vs), 1048 (vs), 1027 (s), 1002 (s), 948 (m), 921 (s), 851 4.30 (d, J = 1.7 Hz, 1 HB, OH), 4.97 (d, J = 1.7 Hz, 1 HB, CHO),
(m) cm–1. MS (EI, 70 eV): m/z (%) = 290 (7) [M+], 184 (100), 149
(71), 132 (17), 79 (35), 77 (62), 57 (52). C16H18O3S (290.38): calcd.
C 66.18, H 6.25; found C 65.85, H 6.26.
5.12 (d, J = 1.4 Hz, 1 HA, CHO), 7.30–7.96 (m, 10 HA, 10 HB,
Ph) ppm. 13C NMR (75 MHz, CDCl3): δ = 8.2 (d, CH3CH2A), 9.3
(d, CH3CH2B), 11.1 (d, MeA), 18.6 (d, MeB), 20.6 (u, CH3CH2A),
26.2 (u, CH3CH2B), 69.5 (u, CSA), 70. 6 (u, CSB), 74.9 (d, COA),
(؎)-2-Ethyl-1-phenyl-2-(phenylsulfonyl)butan-1-ol (13b). From 3b
and PhCHO in THF: Treatment of sulfone 8b (750 mg, 3.53 mmol)
with nBuLi (1.50 m in n-hexane, 2.60 mL, 3.90 mmol) and PhCHO
(750 mg, 7.07 mmol) in THF as described in GP4 gave alcohol 13b
(921 mg, 82%) as colourless crystals.
76.0 (d, CO ), 127.9–138.6 (16 signals, Ph) ppm. IR (KBr): ν =
˜
B
3461 (vs), 3064 (m), 3028 (m), 3001 (m), 2979 (m), 2943 (m), 2202
(w), 957 (w), 1892 (w), 1583 (w), 1494 (m), 1451 (vs), 1391 (m),
1346 (m), 1285 (vs), 1195 (m), 1151 (vs), 1132 (vs), 1074 (vs), 1060
(vs), 1041 (s), 1026 (s), 907 (w), 859 (w), 809 (w) cm–1. MS (EI,
70 eV): m/z (%) = 304 (16) [M+], 198 (100), 183 (92), 163 (76), 105
(43), 143 (48) (33), 79, 77 (81), 57 (39). C17H20O3S (304.40): calcd.
C 67.08, H 6.62; found C 66.84, H 6.53.
From Putative 15Ab and PhCHO in THF: Treatment of sulfone
8b (750 mg, 3.53 mmol) with nBuLi (1.50 m in n-hexane, 2.60 mL,
3.90 mmol), ClTi(OiPr)3 (1.100 g, 4.22 mmol) and PhCHO
(750 mg, 7.07 mmol) in THF as described in GP5 gave alcohol 13b
(899 mg, 80%) as colourless crystals.
(؎)-2-(tert-Butylsulfonyl)-2-methyl-1-phenylpropan-1-ol (13f). From
3f and PhCHO: Treatment of sulfone 8f (750 mg, 4.57 mmol) with
nBuLi (1.50 m in n-hexane, 3.40 mL, 5.10 mmol) and PhCHO
(970 mg, 9.14 mmol) in THF as described in GP4 gave alcohol 13f
(1.087 g, 88%) as colourless crystals.
From 9b and PhCHO in Ether in the Presence of MeI: To a solution
of sulfone 8b (750 mg, 3.53 mmol) in diethyl ether (20 mL) was
added at –78 °C, nBuLi (1.50 m in n-hexane, 2.60 mL, 3.98 mmol).
The yellow mixture was stirred for 15 min at room temperature,
then cooled to –78 °C and treated dropwise with ClTi(OiPr)3
(1.100 g, 4.22 mmol). The orange mixture was stirred for 3 h at
room temperature, cooled to –78 °C and treated with MeI (424 μL,
6.70 mmol). After the mixture was stirred for 30 min at room tem-
perature, it was cooled to –78 °C and treated with PhCHO (116 mg,
10.9 mmol). The mixture was then stirred for 1 d at room tempera-
ture, treated with 2 n aqueous HCl (25 mL) and extracted with di-
ethyl ether (3ϫ 40 mL). Drying (MgSO4) and concentration of the
combined organic phases gave alcohol 13b (1.023 g, 91 %) as
colourless crystals, m.p. 114 °C, Rf = 0.63 (EtOAc/n-hexane, 1:1).
1H NMR (300 MHz, CDCl3): δ = 0.62 (dd, J = 7.4 Hz, 3 H,
CH3CH2), 1.16 (dd, J = 7.6 Hz, 3 H, CH3CH2), 1.53 (dq, J = 7.4,
14.8 Hz, 1 H, CH3CH2), 1.76 (dq, J = 7.4, 14.8 Hz, 1 H, CH3CH2),
2.00 (dq, J = 7.6, 15.4 Hz, 1 H, CH3CH2), 2.25 (dq, J = 7.6,
15.1 Hz, 1 H, CH3CH2), 4.23 (s, 1 H, OH), 4.97 (s, 1 H, CHO),
7.28–7.95 (m, 10 H, Ph) ppm. 13C NMR (75 MHz, CDCl3): δ = 8.4
(d, CH3CH2), 9.4 (d, CH3CH2), 19.3 (u, CH3CH2), 23.9 (u,
CH3CH2), 73.9 (u, CS), 76.1 (d, CO), 128.1 (d), 128.3 (d), 128.9
(d), 130.1 (d, Ph), 128.3 (d), 133.8 (d, Ph), 137.3 (u), 138.9 (u,
From Putative 15Af and PhCHO in THF: Treatment of sulfone 8f
(750 mg, 4.57 mmol) with nBuLi (1.50 m in n-hexane, 3.40 mL,
5.10 mmol), ClTi(OiPr)3 (1.430 g, 5.48 mmol) and PhCHO
(970 mg, 9.13 mmol) in THF as described in GP5 gave alcohol 13f
(865 mg, 70%) as colourless crystals, m.p. 112–114 °C; Rf = 0.58
1
(EtOAc/n-hexane, 1:1). H NMR (300 MHz, CDCl3): δ = 1.18 (s,
3 H, Me), 1.54 (s, 3 H, Me), 1.60 (s, 9 H, tBu), 4.2–4.4 (br. s, 1 H,
OH), 5.41 (s, 1 H, CHO), 7.28–7.40 (m, 5 H, Ph) ppm. 13C NMR
(75 MHz, CDCl3): δ = 16.3 (d, Me), 22.9 (d, Me), 26.0 (d, tBu),
67.3 (u, tBu), 72.6 (u, CS), 75.7 (d, CO), 128.0 (d, Ph), 128.2 (d,
Ph), 128.3 (d, Ph), 138.0 (u, Ph) ppm. IR (KBr): ν = 3415 (vs),
˜
3086 (w), 3060 (m), 3032 (m), 2997 (m), 2937 (m), 2882 (m), 2161
(w), 1957 (w), 1889 (w), 1719 (w), 1602 (m), 1489 (s), 1470 (m),
1452 (s), 1397 (m), 1377 (m), 1365 (s), 1296 (s), 1259 (vs), 1190 (s),
1146 (m), 1131 (s), 1080 (vs), 1062 (vs), 1028 (m), 1004 (s), 962 (m),
946 (m), 919 (w), 854 (m), 801 (w) cm–1. MS (EI, 70 eV): m/z (%)
= 270 (15) [M+], 164 (40), 149 (100), 132 (30), 108 (60), 91 (48), 79
(27), 57 (98). C14H22O3S (270.39): calcd. C 62.19, H 8.20; found C
62.10, H 8.20.
Ph) ppm. IR (KBr): ν = 3493 (vs), 3070 (m), 3031 (w), 2991 (m), (؎)-2-(tert-Butylsulfonyl)-2-ethyl-1-phenylbutan-1-ol (13g). From 3g
˜
2945 (m), 2923 (m), 2884 (m), 2183 (w), 1627 (m), 1583 (m), 1494 and PhCHO: Treatment of sulfone 8g (750 mg, 3.90 mmol) with
(m), 1451 (s), 1386 (m), 1344 (m), 1279 (vs), 1179 (m), 1150 (s), nBuLi (1.50 m in n-hexane, 2.90 mL, 4.35 mmol) and PhCHO
1133 (s), 1110 (s), 1092 (m), 1073 (s), 1056 (s), 1027 (m), 999 (m), (830 mg, 7.82 mmol) in THF as described in GP4 gave alcohol 13g
974 (w), 925 (m), 816 (m) cm–1. MS (EI, 70 eV): m/z (%) = 318 (6) (1.013 g, 87%) as colourless crystals.
[M+], 212 (96), 197 (100), 177 (58), 143 (52), 107 (40), 91 (40), 77
From Putative 15Ag and PhCHO in THF: Treatment of sulfone
(62), 57 (91). C18H22O3S (318.43): calcd. C 67.89, H 6.96; found C
8g (750 mg, 3.90 mmol) with nBuLi (1.50 m in n-hexane, 2.90 mL,
67.70, H 6.88.
4.35 mmol), ClTi(OiPr)3 (1.220 g, 4.68 mmol) and PhCHO
(؎)-2-Methyl-1-phenyl-2-(phenylsulfonyl)butan-1-ol (13c). From 3c (830 mg, 7.82 mmol) in THF as described in GP5 gave alcohol 13g
and PhCHO: Treatment of sulfone 8c (750 mg, 3.78 mmol) with (698 g, 60 %) as colourless crystals, m.p. 117–118 °C; Rf = 0.62
nBuLi (1.50 m in n-hexane, 2.80 mL, 4.20 mmol) and PhCHO
(800 mg, 7.53 mmol) in THF as described in GP4 gave a mixture
of diastereomeric alcohols 13c (990 mg, 86%) in a ratio of 1:1 as
colourless crystals.
(EtOAc/n-hexane, 1:1). 1H NMR (300 MHz, CDCl3): δ = 0.52 (dd,
J = 7.4 Hz, 3 H, CH3CH2), 1.15 (dd, J = 7.4 Hz, 3 H, CH3CH2),
1.61 (s, 9 H, tBu), 1.74 (dq, J = 7.4, 14.8 Hz, 1 H, CH3CH2), 2.01
(dq, J = 7.5, 15.1 Hz, 1 H, CH3CH2), 2.14 (dq, J = 7.5, 14.8 Hz, 1
Eur. J. Org. Chem. 2014, 7134–7147
© 2014 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
7145